$6.39
-0.16-2.44%
At close: -
$6.39
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Phathom Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:PHAT | Benzinga
Phathom Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-1.010
Quarterly Revenue Estimate
$28.02M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$55.25M
Analyze the earnings history of Phathom Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals | -$1.42 | -$1.01 | — | — | $1.91M | $28.02M | — | — | 05/08/2025 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.80 | -$1.08 | -$0.79 | 26.85% | $682.00K | $25.65M | $29.66M | 15.65% | 03/06/2025 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.54 | -$1.49 | -$1.05 | 29.53% | $0.00 | $12.61M | $16.35M | 29.67% | 11/07/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.84 | -$1.38 | -$1.25 | 9.42% | $0.00 | $5.81M | $7.32M | 26.06% | 08/08/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.89 | -$1.24 | -$1.42 | — | $0.00 | $2.05M | $1.91M | -6.73% | 05/09/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.08 | -$1.39 | -28.70% | $0.00 | $410.00K | $682.00K | 66.34% | 03/07/2024 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.32 | -$0.89 | -$0.76 | 14.61% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.33 | -$1.00 | -$0.84 | 16.00% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | -$1.26 | -$0.89 | 29.37% | $0.00 | — | $0.00 | — | 05/10/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.95 | -$1.35 | -$1.33 | 1.48% | $0.00 | — | $0.00 | — | 02/28/2023 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.98 | -$1.32 | -$1.32 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.00 | -$1.03 | -$1.33 | -29.13% | $0.00 | — | $0.00 | — | 08/02/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.96 | -$0.97 | -$1.07 | -10.31% | $0.00 | $210.00K | $0.00 | -100.00% | 05/10/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.58 | -$1.03 | -$0.95 | 7.77% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.02 | -$0.98 | -$0.98 | 0.00% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.64 | -$1.07 | -$1.00 | 6.54% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.62 | -$1.19 | -$0.96 | 19.33% | $0.00 | — | $0.00 | — | 05/11/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$3.97 | — | -$1.58 | — | $0.00 | — | $0.00 | — | 03/30/2021 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$1.07 | — | -$1.02 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | — | — | -$0.64 | — | — | — | $0.00 | — | 08/06/2020 | Get Alert |
| PHAT | Phathom Pharmaceuticals | -$0.19 | — | -$0.62 | — | — | — | $0.00 | — | 05/12/2020 | Get Alert |
Phathom Pharmaceuticals (PHAT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-0.79 | $-1.08 | 26.9 % |
| Q3 | 2024-11-07 | $-1.05 | $-1.49 | 29.5 % |
| Q2 | 2024-08-08 | $-1.25 | $-1.38 | 9.42 % |
| Q4 | 2024-03-07 | $-1.39 | $-1.08 | -28.7 % |
Phathom Pharmaceuticals (PHAT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $29.66M | $25.65M | 15.7 % |
| Q3 | 2024-11-07 | $16.35M | $12.61M | 29.7 % |
| Q2 | 2024-08-08 | $7.32M | $5.81M | 26.1 % |
| Q1 | 2024-05-09 | $1.91M | $2.05M | -6.73 % |
FAQ
When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?
Phathom Pharmaceuticals (PHAT) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Phathom Pharmaceuticals (NASDAQ:PHAT)?
The Actual EPS was $-0.79, which beat the estimate of $-1.08.
What were Phathom Pharmaceuticals’s (NASDAQ:PHAT) revenues?
The Actual Revenue was $29.7M, which beat the estimate of $25.6M.
Browse earnings estimates, EPS, and revenue on all stocks.